Regeneron, Sanofi to iniate human trials of treatment for patients with severe COVID-19

Regeneron, Sanofi to iniate human trials of treatment for patients with severe COVID-19

Source: 
Yahoo/Marketwatch
snippet: 

Regeneron Pharmaceuticals Inc. and Sanofi said Monday said it has initiated a phase 2/3 trial to evaluate Kevzara in patients with severe COVID-19.